Obesity and melanoma: could fat be fueling malignancy?
Emily ClementIkrame LazarCatherine MullerLaurence NietoPublished in: Pigment cell & melanoma research (2017)
Over the last decade, it has become increasingly clear that adipose tissue, and particularly adipocytes, contributes to tumor progression. Obesity, an ever-increasing worldwide phenomenon, exacerbates this effect. The influence of obesity on melanoma remains poorly studied, although recent data do underline an association between the two diseases in both humans and murine models. Herein, we review the impact of obesity on melanoma incidence and progression and discuss the underlying mechanisms known to be involved. Adipose tissue favors the proliferation and aggressiveness of melanoma cells through a direct dialog, mediated by soluble factors and by exosomes, and through remodeling of the tumor microenvironment. This knowledge could, in the future, help to design new personalized therapeutic options for obese melanoma patients.
Keyphrases
- adipose tissue
- insulin resistance
- weight loss
- metabolic syndrome
- high fat diet induced
- type diabetes
- high fat diet
- weight gain
- end stage renal disease
- bariatric surgery
- chronic kidney disease
- skin cancer
- skeletal muscle
- healthcare
- stem cells
- newly diagnosed
- ejection fraction
- signaling pathway
- bone marrow
- poor prognosis
- big data
- obese patients
- machine learning
- basal cell carcinoma
- fatty acid
- electronic health record
- deep learning
- current status
- patient reported outcomes
- data analysis